Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF

Microcirculation

Volumn 8, Issue 1, 2001, Pages 57-67

  Amaral, Sandra L ^a   Linderman, Russell ^a   Morse, Melissa M ^a   Greene, Andrew S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiogenesis; Angiotensin II; Muscle stimulation; Rat; VEGF

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL CELL GROWTH FACTOR; LISINOPRIL; LOSARTAN; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ELECTROSTIMULATION; MALE; PHYSIOLOGY; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ELECTRIC STIMULATION; ENDOTHELIAL GROWTH FACTORS; LISINOPRIL; LOSARTAN; LYMPHOKINES; MALE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035260068     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7300142     Document Type: Article

References (38)

1. Adair TH, Hang J, Wells ML, Magee FD, Montani J-P. (1995). Long-term electrical stimulation of rabbit skeletal muscle increases growth of paired arteries and veins. Am J Physiol 269:H717-H724.
2. Annex BH, Torgan CE, Lin P, Taylor DA, Thompson MA, Peters KG, Kraus WE. (1998). Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol 274:H860-H867.
3. Breen EC, Johnson EC, Wagner H, Tseng H-M, Sung LA, Wagner PD. (1996). Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 81(1):355-361.
4. Carmeliet P, Collen D. (1999). Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 237:133-158.
5. 189. Proc Natl Acad Sci USA 94:12081-12087.
6. Chua CC, Hamdy RC, Chua BHL. (1998). Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1401:187-194.
7. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. (1998). Animal model: mouse model of angiogenesis. Am J Pathol 152:1667-1679.
8. Dawson JM, Hudlicka O. (1993). Can changes in microcirculation explain capillary growth in skeletal muscle? Int J Exp Path 74:65-71.
9. Fabre J-E, Rivard A, Magner M, Silver M, Isner JM. (1999). Tissue inhibition of angiotensin converting enzyme activity stimulates angiogenesis in vivo. Circulation 99:3043-3049.
10. Ferrara N, Davis-Smyth T. (1997). The biology of vascular endothelial growth factor. Endocr Rev 18(1): 4-24.
11. Ferrara N, Houck K, Jakeman L, Leung DW. (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13(1):18-32.
12. Ferrara N. (1999). Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237:1-29.
13. Forsythe JA, Jiang B-H, Iyer NV, Again F, Leung SW, Koos RT, Semenza GL. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-iriducible factor 1. Mol Cell Biol 16(9): 4604-4613.
14. Gavin TP, Spector DA, Wagner H, Breen EC, Wagner PD. (2000). Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J Appl Physiol 88:1192-1198.
15. Greene AS, Lombard JH, Cowley AC Jr, Hansen-Smith FM. (1990). Microvessel changes in hypertension measured by Griffonia simplicifolia I lectin. Hypertension 15:779-783.
16. Gu JW, Adair TH. (1997). Hypoxia-induced expression of VEGF is reversible in myocardial vascular smooth muscle cells. Am J Physiol 273:H628-H633.
17. Hang J, Kong L, Gu JW, Adair TH. (1995). VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am J Physiol 269-H1827-H1831.
18. Hansen-Smith FM, Egginton S, Hudlicka O. (1998). Growth of arterioles in chronically stimulated adult rat skeletal muscle. Microcirculation 5:49-59.
19. Hudlicka O, Brown MD, Egginton S. (1992). Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72(2):369-417.
20. Hudlicka O. (1998). Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 5:7-23.
21. G-L-arginine, nitric oxide synthase inhibitor. Microvasc Res 59:45-51.
22. Kanno S, Oda N, Abe M, Saito S, Hori K, Handa Y, Tabayashy K, Sato Y. (1999). Establishment of a simple and practical procedure applicable to therapeutic angiogenesis. Circulation 99:2682-2687.
23. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N. (1989). Vascular endothelial growth factor is a secreted angiogenic initogen. Science 246: 1306-1309.
24. Linderman JR, Kloehn MR, Greene AS. (2000). Development of an implantable muscle stimulator: measurement of stimulated-angiogenesis and post-stimulus vessel regression. Microcirculation 7:119-128.
25. Morse MM, Clark JS, Greene AS. (2000). Evidence for a local renin-angiotensin system in the skeletal muscle microvasculature. FASEB J 14(4):A141.
26. Munzenmaier DH, Greene AS. (1996). Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27(part 2): 760-765.
27. Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J. (1997). Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273:H2224-H2231.
28. Nicosia RF, Lin YJ, Hazelton D, Qian X. (1997). Endogenous regulation of angiogenesis in the rat aorta model: role of vascular endothelial growth factor. Am J Pathol 151:1379-1386.
29. Norrby K. (1996). Vascular endothelial growth factor and de novo mammalian angiogenesis. Microvasc Res 51:153-163.
30. Papanek PE, Rieder MJ, Greene AS. (1996). Captopril blocks angiogenic response to short-term exercise. Microcirculation 3(1):100.
31. Pupilli C, Lasagni L, Romagnani P, Bellini F, Mannelli M, Misciglia N, Mavilia C, Vellei U, Villari D, Serio M. (1999). Angiotensin II stimulates the synthesis and secretion of vascular permeability factor / vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol 10(2):245-255.
32. Rieder MJ, O'Drobinak DM, Greene AS. (1995). A computerized method for determination of microvascular density. Microvasc Res 49:180-189.
33. Rieder MJ, Roman RJ, Greene AS. (1997). Reversal of microvascular rarefaction and reduced renal mass hypertension. Hypertension 30(part 1):120-127.
34. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P. (1998). Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673.
35. Shweiki D, Itin A, Soffer D, Keshet E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(29):843-845.
36. Williams B, Baker AQ, Gallacher B, Lodwick D. (1995). Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25:913-917.
37. 121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of the chorioallantoic membrane. Dev Biol 176:76-85.
38. Zheng W, Brown MD, Brock TA, Bjerke RJ, Tomanek RJ. (1999). Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Cir Res 85:192-198.